












Daniel Mukasa
CEO at AbInitio Bio
Founder & CEO at AbInitio Bio (YC P26). Postdoctoral Fellow at MIT focused on AI and drug discovery. Previously AI/ML intern at Merck working on antibody therapeutic design. PhD in Applied Physics and Materials Science from Caltech.
Follow Daniel
Previously at

Massachusetts Institute of Technology (MIT)

Merck
Alumnus of

Massachusetts Institute of Technology

California Institute of Technology